- Abstract
1
- 10.1016/j.anai.2019.08.075
D302 PERCEPTIONS AMONG PEANUT-ALLERGIC CHILDREN: A SURVEY
- Nov 01, 2019
- Annals of Allergy, Asthma & Immunology
- M Greenhawt + 7 more +7
Publications from 2021 to 2026
Showing 6 of 6 papers
D302 PERCEPTIONS AMONG PEANUT-ALLERGIC CHILDREN: A SURVEY
D300 PATIENT EXPERIENCES FOLLOWING THE OLFUS VIPES PHASE IIB EPICUTANEOUS IMMUNOTHERAPY TRIAL: A RETROSPECTIVE QUALITATIVE STUDY
Symptomatic Acquired Zinc Deficiency in At-Risk Premature Infants: High Dose Preventive Supplementation Is Necessary
Zinc is a cofactor for several enzymes involved in many metabolisms. Zinc deficiency induces various disorders such as acrodermatitis enteropathica, either inherited or acquired. We report three cases of premature infants (24-31 wks gestational age) with low birthweight (650 to 940 g) and enteropathy, two of whom presented with necrotizing enterocolitis. All infants were fed by total parenteral nutrition. At a chronological age ranging from 73 to 80 days, all infants developed a periorificial dermatitis. Before the onset of the first signs, they had received zinc supplementation ranging from 146% to 195% of the recommended dose (400 microg/kg/day). Increased zinc supplementation over a course of 6-18 days induced a complete resolution of symptoms in all cases. No abnormality in the neurologic examination and no recurrence were observed at the end of the zinc treatment. Low birthweight premature infants with enteropathy on total parenteral nutrition are at risk of developing zinc deficiency. The usual recommended zinc supplementation is probably insufficient for those infants. A delay in the diagnosis of zinc deficiency may lead to severe complications.
Read morePotential Antioxidant Effects of Zinc and Chromium Supplementation in People with Type 2 Diabetes Mellitus
Objective: To determine the effects of combined zinc (Zn) and chromium (Cr) supplementation on oxidative stress and glucose homeostasis of people with type 2 diabetes.Design: Tunisian adult subjects with HbA1C >7.5% were supplemented for 6 months with 30 mg/d of Zn as Zn gluconate or 400 μg/d of Cr as Cr pidolate or combined Zn/Cr supplementation or placebo. The effects of supplementation on plasma zinc (Zn), copper (Cu), selenium (Se), urinary Zn, Cr, plasma thiobarbituric acid reactive substances (TBARS), Cu-Zn superoxide dismutase (SOD) and Se glutathione peroxidase (GPx) in red blood cells, blood lipids and lipoproteins, HbA1C and fasting glucose were measured at the beginning of the study and after six months.Results: At the beginning of the study, more than 30% of the subjects may have been Zn deficient with plasma Zn values less than 10.7 μmol/L, whereas levels of plasma Cu, Se and antioxidant RBC enzyme activities were in the normal ranges. Following supplementation, there were significant decreases of plasma TBARS in the Cr (13.6%), Zn (13.6%) and Zn/Cr (18.2%) groups with no significant changes in the placebo group. The value for the TBARS of the control healthy Tunisian subjects was 2.08 ± 0.04 μmol/L and that of the Tunisian subjects with diabetes was 3.32 ± 0.05 μmol/L. This difference of 1.24 μmol/L between the control group and the subjects with diabetes was reduced from 36% to 50% in the three supplemented groups. Supplementation did not modify significantly HbA1C nor glucose homeostasis. No adverse effects of Zn supplementation were observed on Cu status, HDL cholesterol nor interactions in Zn or Cr.Conclusions: These data suggest the potential beneficial antioxidant effects of the individual and combined supplementation of Zn and Cr in people with type 2 DM. These results are particularly important in light of the deleterious consequences of oxidative stress in people with diabetes.
Read moreHierarchical author networks: An analysis of European molecular biology laboratory (EMBL) publications
Co-authorship analyses are both difficult to perform and interpret. We have devised a new way of calculating and representing hierarchical author networks that depict relationships among authors in a more exhaustive and less equivocal manner than most available automatic analyses. Any structure, however complex, can be broken down into independent subclusters of authors that can be represented as individual interconnected networks. We illustrate our approach by analysing the authors of publications giving the European Molecular Biology Laboratory (EMBL) as an affiliation in 1994 (from the ISI 1994 CD-ROM). The networks can be interpreted by referring to the official EMBL staff list (Annual Report 1993) and, in terms of research topics, by consulting the article titles and abstracts. In this respect, correspondence analyses of the author-publication matrices—that are the counterparts of the author-author matrices—prove extremely useful in structuring the thematic information. In fact, both methods—the hierarchical author networks and the correspondence analysis biplots—mutually enrich each other and provide a global picture of the inherent structure and interests of the EMBL as given by their 1994 publications.
Read moreBlood levels of copper, iron, zinc, and lead in adults in India and Pakistan and the effect of oral zinc supplementation for six weeks.
Deficiency in the intake of trace elements, such as copper (Cu), iron (Fe), selenium (Se), and zinc (Zn), is very common in the general population of most developing countries. A preliminary study in India and Pakistan showing the plasma levels of Zn and Fe indicates that approx 50% of the subjects who participated have low levels of both Fe and Zn, suggesting a marginal deficiency. The low plasma levels of these elements are more pronounced in females. The mean levels of Ze, Cu, and Fe in the plasma of 83 subjects were 0.71 +/- 0.11, 0.96 +/- 0.10, and 0.80 +/- 0.12 mg/L, respectively. The Cu:Zn ratio in the plasma was 1.43 +/- 0.16. Three groups of 15 subjects each were given three different levels of oral supplements of Zn (15, 30, and 45 mg of Zn as Zn gluconate) for 6 wk, and blood samples were analyzed during various intervals. Plasma concentration of Zn increased significantly (p < 0.001) in all the groups after 4 wk of supplementation and reached almost normal levels after 6 wk. Along with the increase in Zn, there was a significant decrease (p < 0.001) in plasma Cu levels. There were no changes in the concentration of Fe during the supplementation period. The supplementation was well tolerated by most subjects. The results of this pilot study indicate that Zn supplementation is a practical possibility comparable to that of Fe supplementation in order to prevent marginal Zn deficiency in vulnerable groups in the general population of developing countries.
Read more